NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)
Close on Nov 17, 2026Market cap $94.88MP/E –Yield –
NovaBridge Biosciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
NovaBridge Biosciences's EV/EBITDA was 16.5× on Feb 28, 2022, against 45.6× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Feb 28, 2022 | 16.5× | −17.5 |
| 2021 | Dec 31, 2021 | 33.9× | – |
See a number that looks wrong?